Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells
|
journal
|
June 2014 |
Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation
|
journal
|
October 2013 |
Conformational changes in IgE contribute to its uniquely slow dissociation rate from receptor FcɛRI
|
journal
|
April 2011 |
IgE Enhances Antibody and T Cell Responses In Vivo via CD23 + B Cells
|
journal
|
July 2005 |
Accelerated disassembly of IgE–receptor complexes by a disruptive macromolecular inhibitor
|
journal
|
October 2012 |
IgE and mast cells in allergic disease
|
journal
|
May 2012 |
A novel IgE-neutralizing antibody for the treatment of severe uncontrolled asthma
|
journal
|
February 2014 |
“Auto-anti-IgE”: Naturally occurring IgG anti-IgE antibodies may inhibit allergen-induced basophil activation
|
journal
|
December 2014 |
Soluble CD23 Controls IgE Synthesis and Homeostasis in Human B Cells
|
journal
|
March 2012 |
Monitoring free serum IgE in severe asthma patients treated with omalizumab
|
journal
|
November 2012 |
Regulation of Syk kinase and FcRβ expression in human basophils during treatment with omalizumab
|
journal
|
April 2010 |
IgE in allergy and asthma today
|
journal
|
March 2008 |
Granzyme B, a novel mediator of allergic inflammation: its induction and release in blood basophils and human asthma
|
journal
|
October 2006 |
Regulation of IgE Synthesis by CD23/CD21 Interaction
|
journal
|
January 1995 |
A single glycan on IgE is indispensable for initiation of anaphylaxis
|
journal
|
March 2015 |
Omalizumab-induced reductions in mast cell FcεRI expression and function
|
journal
|
September 2004 |
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
|
journal
|
August 2001 |
Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics and symptoms in patients with severe persistent allergic (IgE-mediated) asthma
|
journal
|
July 2009 |
High affinity targeting of CD23 inhibits IgE synthesis in human B cells.
|
text
|
January 2015 |
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study
|
journal
|
March 2015 |
Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects
|
journal
|
October 2014 |
Inference of Macromolecular Assemblies from Crystalline State
|
journal
|
September 2007 |
UCSF Chimera?A visualization system for exploratory research and analysis
|
journal
|
January 2004 |
Use of Omalizumab in the Treatment of Food Allergy and Anaphylaxis
|
journal
|
October 2012 |
Conformational Flexibility in Immunoglobulin E-Fc3–4 Revealed in Multiple Crystal Forms
|
journal
|
October 2009 |
The eXpeRience registry: The ‘real-world’ effectiveness of omalizumab in allergic asthma
|
journal
|
August 2013 |
Structure of the Human IgE-Fc Cε3-Cε4 Reveals Conformational Flexibility in the Antibody Effector Domains
|
journal
|
September 2000 |
CD21 is a ligand for CD23 and regulates IgE production
|
journal
|
August 1992 |
Negative feedback regulation of IgE synthesis by murine CD23
|
journal
|
June 1994 |
Oral Immunotherapy and Anti-IgE Antibody-Adjunctive Treatment for Food Allergy
|
journal
|
February 2012 |
A time-resolved fluorescence resonance energy transfer assay suitable for high-throughput screening for inhibitors of immunoglobulin E–receptor interactions
|
journal
|
December 2012 |
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
Role of Glycosylation Sites in the IgE Fc Molecule
|
journal
|
January 1995 |
Omalizumab treatment downregulates dendritic cell FcεRI expression
|
journal
|
December 2003 |
Antibody neutralization and escape by HIV-1
|
journal
|
March 2003 |
In vivo enhancement of the specific antibody response via the low-affinity receptor for IgE
|
journal
|
July 1993 |
Facilitated dissociation of IgE versus cell replacement
|
journal
|
January 2015 |
Structural and Physical Basis for Anti-IgE Therapy
|
journal
|
June 2015 |
The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update: The ‘hygiene hypothesis’: an update
|
journal
|
March 2010 |
PHENIX: a comprehensive Python-based system for macromolecular structure solution.
|
text
|
January 2010 |
Coot model-building tools for molecular graphics
|
journal
|
November 2004 |
Perivascular Mast Cells Dynamically Probe Cutaneous Blood Vessels to Capture Immunoglobulin E
|
journal
|
January 2013 |
An Unusual Mechanism for Ligand Antagonism
|
journal
|
July 1998 |
Crystal structure of IgE bound to its B-cell receptor CD23 reveals a mechanism of reciprocal allosteric inhibition with high affinity receptor Fc RI
|
journal
|
July 2012 |
DARPins against a functional IgE epitope
|
journal
|
October 2010 |
Suppression of the basophil response to allergen during treatment with omalizumab is dependent on 2 competing factors
|
journal
|
November 2012 |
High affinity targeting of CD23 inhibits IgE synthesis in human B cells: High affinity targeting of CD23
|
journal
|
July 2015 |
Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcεRIα
|
journal
|
July 2000 |
Structure of the omalizumab Fab
|
journal
|
March 2015 |
An Engineered Disulfide Bond Reversibly Traps the IgE-Fc 3–4 in a Closed, Nonreceptor Binding Conformation
|
journal
|
September 2012 |
Characterization of truncated alpha chain products from human, rat, and mouse high affinity receptor for immunoglobulin E
|
journal
|
February 1991 |
A monoclonal anti-IgE antibody against an epitope (amino acids 367-376) in the CH3 domain inhibits IgE binding to the low affinity IgE receptor (CD23).
|
journal
|
November 1988 |
Binding the low affinity Fc epsilon R on B cells suppresses ongoing human IgE synthesis.
|
journal
|
January 1989 |
Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody.
|
journal
|
February 1997 |
The binding site on human immunoglobulin E for its high affinity receptor
|
journal
|
October 1994 |